Logotype for CTT Systems

CTT Systems (CTT) Q3 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for CTT Systems

Q3 2025 earnings summary

24 Oct, 2025

Executive summary

  • System sales surged 80% year-to-date, with strong Q3 momentum and major retrofit deliveries, including a 146-unit order for Jet2.com.

  • Letter of intent signed with Boeing Business Jets to offer cabin humidification as standard, and OEM partnership with Liebherr Aerospace for the COMAC C929 program.

  • Q3 net sales rose 29% year-over-year to MSEK 74, with strong growth in Private Jet, OEM, and retrofit segments.

  • Operating profit (EBIT) increased to MSEK 19, with a 25% margin; EPS was SEK 1.15.

  • Operating cash flow surged to MSEK 33, exceeding EBITDA, driven by positive working capital changes.

Financial highlights

  • Q3 net sales increased 29% year-over-year to MSEK 74; at fixed FX, up 39%.

  • EBIT margin in Q3 was 25% (down from 26% last year); EPS increased to SEK 1.15.

  • Operating cash flow for Jan–Sep was MSEK 40.8, with cash and equivalents at MSEK 34.8 as of September 30.

  • Year-to-date 2025 net sales decreased 5% to MSEK 208, EBIT dropped 49% to MSEK 41, and EPS fell 46% to 2.63 SEK.

  • Order intake SEK 48 million (down from SEK 69 million); backlog SEK 129 million (up from SEK 47 million).

Outlook and guidance

  • No specific guidance for Q4 due to currency volatility, shorter lead times, and changing distributor behavior.

  • Aftermarket sales expected to recover in 2026, with installed base of humidifiers projected to grow over 20% per year as Airbus and Boeing ramp up production.

  • OEM order momentum expected to pick up end-2025/early 2026, with a strong outlook for 2026/2027.

  • Margins and profit expected to improve in 2026, driven by higher sales and cost reductions.

  • Private jet segment establishing a higher net sales baseline, driven by increased penetration in narrowbody VIPs.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more